The Role of IL-6, IL-10, and TNF-α in Ocular GVHD Following Allogeneic Transplantation-Reference-Cited by-同舟云学术

The Role of IL-6, IL-10, and TNF-α in Ocular GVHD Following Allogeneic Transplantation

Published:2024-01-22 Issue: Volume: Page:1-8
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Chen Yingjie¹,Zhuang Xinyu¹,Wang Lei²,Xu Yue¹,Sun Zhengtai³,Ren Yaru³,Chen Feng⁴⁵,Ma Xiao⁴⁵,Tang Xiaowen⁴⁵,Zhang Xiaofeng¹³

Affiliation:

1. Department of Ophthalmology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, China

2. Department of Ophthalmology, Suzhou Municipal Hospital, Nanjing Medical University Affiliated Suzhou Hospital, Suzhou, China

3. Department of Ophthalmology, First Affiliated Hospital of Soochow University, Suzhou, China

4. National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

5. Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China

Funder

Key Medical Support Disciplines of Suzhou

Suzhou Clinical Key Diseases Diagnosis

Treatment Technology Special Project

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2024.2302445

Reference36 articles.

1. World Health Organization (WHO). Haematopoietic stem cell transplantation HSCtx [web page]. Geneva Switzerland: WHO. https://www.who.int/transplantation/hsctx/en. 2018. Accessed January 6 2019.

2. Dry eye after haematopoietic stem cell transplantation

3. Validation of Measurement Scales in Ocular Graft-versus-Host Disease

4. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

5. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report